Immunogenicity 11083

summary
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SUCLG2
Transcript ID
None
HLA INFO
A*03:01
TCR INFO

No TCR info found!

T cell Tumor cell A*03:01
sequence
Full length protein sequence (440 aa)
MASPV
1
AAQAG
6
KLLRA
11
LALRP
16
RFLAA
21
GSQAV
26
QLTSR
31
RWLNL
36
QEYQS
41
KKLMS
46
DNGVR
51
VQRFF
56
VADTA
61
NEALE
66
AAKRL
71
NAKEI
76
VLKAQ
81
ILAGG
86
RGKGV
91
FNSGL
96
KGGVH
101
LTKDP
106
NVVGQ
111
LAKQM
116
IGYNL
121
ATKQT
126
PKEGV
131
KVNKV
136
MVAEA
141
LDISR
146
ETYLA
151
ILMDR
156
SCNGP
161
VLVGS
166
PQGGV
171
DIEEV
176
AASNP
181
ELIFK
186
EQIDI
191
FEGIK
196
DSQAQ
201
RMAEN
206
LGFVG
211
PLKSQ
216
AADQI
221
TKLYN
226
LFLKI
231
DATQV
236
EVNPF
241
GETPE
246
GQVVC
251
FDAKI
256
NFDDN
261
AEFRQ
266
KDIFA
271
MDDKS
276
ENEPI
281
ENEAA
286
KYDLK
291
YIGLD
296
GNIAC
301
FVNGA
306
GLAMA
311
TCDII
316
FLNGG
321
KPANF
326
LDLGG
331
GVKEA
336
QVYQA
341
FKLLT
346
ADPKV
351
EAILV
356
NIFGG
361
IVNCA
366
IIANG
371
ITKAC
376
RELEL
381
KVPLV
386
VRLEG
391
TFMEK
396
KGSYM
401
HIKQE
406
TGNSN
411
ENITG
416
IQENV
421
AHQNL
426
SKCAI
431
SIFLC
436
Mutation Information
DNA mutation:
None
Peptide Range:
402 ~ 426
Mut AA position:
414 (13 in Wild Type peptide)
Alignment
Wild Type:
"GSYMHIKQETGNSNENITGIQENVA
||||||||||||.||||||||||||
Mutant:
GSYMHIKQETGNLNENITGIQENVA"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

ELISPOT assay